Pharma Tariffs: Indian Pharma Exports And Impact On Stocks | Narendra Solanki Analyses | ET Now

Narendra Solanki on ET Now analyzed pharma tariffs, noting Donald Trump's review could impact Indian pharma exports, valued at $8.7 billion to the U.S. Potential tariffs may raise costs, affecting stocks like Sun Pharma and Dr. Reddy’s. Indian firms might diversify to offset risks, influencing market performance.

#pharmasectortariffs #etnow #trumptariffs #pharmasector #pharmastocks #aurobindopharma #sunpharma #topnews #businessnews #stockmarket #ayeshafaridi

control your money with economic times now.

YouTube Channel - https://www.youtube.com/@ETNow

Subscribe To ET Now For Latest Updates On Stocks Market News , Business News, Company News, IPO & More | https://bit.ly/SubscribeToETNow

Subscribe Now To Our Network Channels :-
ET Now Swadesh: https://www.youtube.com/etnowswadesh
Times Now: http://goo.gl/U9ibPb
Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC

Website - https://www.etnownews.com

Follow us on Google News for latest updates
ET Now: https://news.google.com/publications/CAAqBwgKMK3HxQsw0OLcAw?hl=en-IN&gl=IN&ceid=IN%3Aen
Times Now Navbharat: https://bit.ly/3zDaKJo
Times Now : https://bit.ly/3CyrrYg
Zoom: https://bit.ly/3CEK0dv

Видео Pharma Tariffs: Indian Pharma Exports And Impact On Stocks | Narendra Solanki Analyses | ET Now канала ET NOW
control your money, economic times now, pharma stocks, trump tariffs, pharma tariffs, indian pharma, stock market crash, trade war, us tariffs, market volatility, financial markets, nifty pharma, sensex, nifty, indian stock market, economic slowdown, global trade impact, pharmaceutical industry, investor sentiment, stock market news, equity markets, drug pricing, export restrictions, market outlook, healthcare stocks, trading strategy, et now, ayesha faridi